ctrl K

Price Alert

GSK (GSK)

NYSE: GSK · Real-Time Price · USD

39.22

0.09 (0.23%)

At close: Aug 14, 2025, 3:59 PM

38.77

-1.15%

Pre-market: Aug 15, 2025, 04:33 AM EDT

GSK Balance Sheet Statement

Financials in GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.69B	2.75B	3.72B	4.27B
Short-Term Investments	21M	2.25B	4.15B	61M
Long-Term Investments	1.21B	2.14B	-2.61B	2.15B
Other Long-Term Assets	1.93B	634M	5.35B	1.75B
Receivables	6B	5.91B	5.45B	6.25B
Inventory	5.67B	5.5B	5.15B	5.78B
Other Current Assets	1.23B	1.2B	1.1B	1.36B
Total Current Assets	17B	18.64B	20.77B	18.67B
Property-Plant & Equipment	10.07B	9.96B	9.62B	10.67B
Goodwill & Intangibles	22.5B	21.58B	21.36B	40.63B
Total Long-Term Assets	42.47B	40.36B	39.38B	60.43B
Total Assets	59.46B	59.01B	60.15B	79.1B
Account Payables	3.46B	3.72B	3.87B	4.54B
Deferred Revenue	n/a	222M	299M	1.56B
Short-Term Debt	2.18B	2.66B	3.79B	3.4B
Other Current Liabilities	14.76B	9.39B	12.73B	13.27B
Total Current Liabilities	21.7B	21.07B	22.81B	23.67B
Long-Term Debt	13.7B	14.15B	16.19B	19.76B
Other Long-Term Liabilities	9.5B	9.37B	9.83B	9.88B
Total Long-Term Liabilities	24.68B	25.14B	27.24B	34.09B
Total Liabilities	46.38B	46.21B	50.05B	57.76B
Total Debt	16.99B	18.02B	20.99B	24.17B
Common Stock	1.35B	1.35B	1.35B	1.35B
Retained Earnings	7.8B	7.24B	4.36B	7.94B
Comprehensive Income	n/a	n/a	-48M	642M
Shareholders Equity	13.67B	13.35B	10.6B	15.05B
Total Investments	1.23B	4.39B	1.54B	2.21B